PharmaNutra Plc. is a pharmaceutical company established in 2003 in Pisa, dedicated to the development of nutraceutical supplements and medical devices. In particular, the Group carries out activities related to the research, design, development and marketing of its innovative products. Among its most important achievements are the SiderAL® branded products, based on Sucrosomial® Iron, and the Cetilar® branded products, intended to improve articulations movement and bring relief to joints affected by osteoarthritis.
PharmaNutra closely monitors the entire manufacturing process, starting from raw materials to finished products. Furthermore, the Group has the know-how to manage all the phases from design and development to registration, marketing and sales. Since 2005, PharmaNutra develops and markets directly its own product line on an independent basis, through an exclusive network of Sales Representatives.
The Group is composed by PharmaNutra Plc (holding company), Alesco Ltd, manufacturer and distributor of raw materials (active ingredients) for the pharmaceutical, food and dietary supplement industry and Junia Pharma Ltd, developing and distributing drugs, medical devices, OTC and nutritional supplements with special attention to the pediatric area. The Group has settled its own strategy in the production and management of the intellectual property, based on the integrated management of company assets: proprietary raw materials, patents, brands and clinical trials. Since July 2017 PharmaNutra has been admitted to trading on the AIM Italia/Alternative Capital Market.
PharmaNutra Group distributes and sells products in Italy and abroad. In Italy the sales activities are carried out by a network of about 180 Sales Representatives, providing scientific information to medical professionals and selling PharmaNutra products to the pharmacies all over Italy. In addition, supply of wholesalers directly to pharmacies and para-pharmacies assures that the Italian market is completely covered. The Sale Representative network approach is based on a specific and innovative marketing model adopted by PharmaNutra Group in Italy since 2009. Although the international expansion began only in 2014, nowadays PharmaNutra operates in 70 countries (in Europe, Asia, America and Africa) through 35 key partners, carefully selected among the world top pharmaceutical companies, that market and sell the Group's products with territorial exclusivity.
